Abstract: [Problem] To provide a pharmaceutical composition for treating FGFR4 related cancer FGF19 related cancer or FGF19 gene amplification positive liver cancer. [Solution] The inventors perfected the present invention through study of compounds having FGFR4 inhibitory effect verifying that specific pyrimidine compounds have FGFR4 inhibitory effect and that pharmaceutical compositions having these compounds as active ingredients have therapeutic effect against FGFR4 related cancer or in another mode against FGF19 related cancer or in yet another mode against FGF19 gene amplification positive liver cancer.
SOFT COPY ATTACHED IN PDF
| # | Name | Date |
|---|---|---|
| 1 | 201647006685-Correspondence-F1-240816.pdf | 2016-09-21 |
| 1 | Power of Attorney [26-02-2016(online)].pdf | 2016-02-26 |
| 2 | 201647006685-Form 1-240816.pdf | 2016-09-21 |
| 2 | Form 5 [26-02-2016(online)].pdf | 2016-02-26 |
| 3 | Form 3 [23-08-2016(online)].pdf | 2016-08-23 |
| 3 | Form 3 [26-02-2016(online)].pdf | 2016-02-26 |
| 4 | Form 1 [26-02-2016(online)].pdf | 2016-02-26 |
| 4 | Other Patent Document [23-08-2016(online)].pdf | 2016-08-23 |
| 5 | Description(Complete) [26-02-2016(online)].pdf | 2016-02-26 |
| 5 | 201647006685.pdf | 2016-06-08 |
| 6 | 201647006685.pdf | 2016-06-08 |
| 6 | Description(Complete) [26-02-2016(online)].pdf | 2016-02-26 |
| 7 | Form 1 [26-02-2016(online)].pdf | 2016-02-26 |
| 7 | Other Patent Document [23-08-2016(online)].pdf | 2016-08-23 |
| 8 | Form 3 [23-08-2016(online)].pdf | 2016-08-23 |
| 8 | Form 3 [26-02-2016(online)].pdf | 2016-02-26 |
| 9 | 201647006685-Form 1-240816.pdf | 2016-09-21 |
| 9 | Form 5 [26-02-2016(online)].pdf | 2016-02-26 |
| 10 | Power of Attorney [26-02-2016(online)].pdf | 2016-02-26 |
| 10 | 201647006685-Correspondence-F1-240816.pdf | 2016-09-21 |